终生慢性肾脏病中的基因组疾病
本研究在儿童和成人慢性肾脏病(CKD)队列中检测基因组疾病(GD)的患病率,并与对照组比较。结果显示GD在儿童和成人CKD中均富集,且与低血清镁、低教育水平和死亡风险升高相关;表型组关联分析证实肾病与GD的关联。
要点
- 儿童CKD队列II中248例有9例(3.6%)携带GD,重复了既往儿童CKD的发现。
- 成人CKD患者中GD患病率为1.1%(72/6679),高于对照组的0.65%(199/30746),OR为1.7(95%CI 1.3至2.2)。
- 17q12 GD(肾囊肿与糖尿病综合征的诊断标志)最常见,在CKD合并糖尿病患者中为1:252。
核心结论
- 未诊断的GD在儿童和成人CKD中均可检测到,识别GD可提供精确遗传诊断、辅助预后判断并帮助临床研究中的风险分层。
研究设计与样本
- 研究分析了慢性肾脏病儿童队列II(CKiD II,n=248)、慢性肾功能不全队列研究(CRIC,n=3375)、哥伦比亚大学CKD生物样本库(CU-CKD,n=1986)和家族性肾病与糖尿病研究(FIND,n=1318)的参与者,并与30746名对照比较。
- 另在电子病历与基因组学(eMERGE,n=11146)队列中进行了GD的表型组关联分析(PheWAS)。
主要发现
- CKiD II队列248例中有9例(3.6%)携带GD,重复了既往儿童CKD的发现。
- CRIC、CU-CKD和FIND队列6679例成人CKD患者中72例(1.1%)检出GD,对照组30746例中199例(0.65%)检出GD,OR为1.7(95%CI 1.3至2.2)。
- 成人CKD中反复出现的GD位于1q21.1、16p11.2、17q12和22q11.2位点;17q12 GD最常见,在CKD合并糖尿病患者中为1:252。
- PheWAS中透析和神经精神表型与GD的关联最强。
- CRIC参与者中GD与较低血清镁、较低教育成就和较高死亡风险相关。
临床怎么用
- 系统性检测GD可为CKD患者提供分子诊断并改善风险与预后预测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: Pathogenic structural genetic variants, also known as genomic disorders, have been associated with pediatric CKD. This study extends those results across the lifespan, with genomic disorders enriched in both pediatric and adult patients compared with controls. In the Chronic Renal Insufficiency Cohort study, genomic disorders were also associated with lower serum Mg, lower educational performance, and a higher risk of death. A phenome-wide association study confirmed the link between kidney disease and genomic disorders in an unbiased way. Systematic detection of genomic disorders can provide a molecular diagnosis and refine prediction of risk and prognosis. BACKGROUND: Genomic disorders (GDs) are associated with many comorbid outcomes, including CKD. Identification of GDs has diagnostic utility. METHODS: We examined the prevalence of GDs among participants in the Chronic Kidney Disease in Children (CKiD) cohort II ( n =248), Chronic Renal Insufficiency Cohort (CRIC) study ( n =3375), Columbia University CKD Biobank (CU-CKD; n =1986), and the Family Investigation of Nephropathy and Diabetes (FIND; n =1318) compared with 30,746 controls. We also performed a phenome-wide association analysis (PheWAS) of GDs in the electronic MEdical Records and GEnomics (eMERGE; n =11,146) cohort. RESULTS: We found nine out of 248 (3.6%) CKiD II participants carried a GD, replicating prior findings in pediatric CKD. We also identified GDs in 72 out of 6679 (1.1%) adult patients with CKD in the CRIC, CU-CKD, and FIND cohorts, compared with 199 out of 30,746 (0.65%) GDs in controls (OR, 1.7; 95% CI, 1.3 to 2.2). Among adults with CKD, we found recurrent GDs at the 1q21.1, 16p11.2, 17q12, and 22q11.2 loci. The 17q12 GD (diagnostic of renal cyst and diabetes syndrome) was most frequent, present in 1:252 patients with CKD and diabetes. In the PheWAS, dialysis and neuropsychiatric phenotypes were the top associations with GDs. In CRIC participants, GDs were associated with lower serum magnesium, lower educational achievement, and higher mortality risk. CONCLUSION: Undiagnosed GDs are detected both in children and adults with CKD. Identification of GDs in these patients can enable a precise genetic diagnosis, inform prognosis, and help stratify risk in clinical studies. GDs could also provide a molecular explanation for nephropathy and comorbidities, such as poorer neurocognition for a subset of patients.
引用
- Verbitsky M, Krishnamurthy S, Krithivasan P, et al. Genomic Disorders in CKD across the Lifespan. J Am Soc Nephrol. 2022. PMID: 36302597. doi:10.1681/ASN.2022060725
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。